Opexa Pharmaceuticals Inc., PharmaFrontiers deal

PFTR will acquire Opexa for 2.5 million shares valued at $21.3 million using PFTR's Oct. 8 close of $8.50. Opexa will become a wholly- owned subsidiary of PFTR, and Opexa shareholders will own about 2...